NCT05450640View on ClinicalTrials.gov

Satisfaction Regarding the Dispensing of Emicizumab (HEMLIBRA®) for Patients With Haemophilia A in France

CompletedOBSERVATIONAL

Enrollment

176

Participants

Timeline

Start Date

January 9, 2023

Primary Completion Date

January 9, 2023

Study Completion Date

January 9, 2023

Conditions

Hemophilia A

Interventions

OTHER

satisfaction survey

1 eQuestionnaire per patient completed during study

Trial Locations (1)

Unknown

Hospices Civils de Lyon, Bron

All Listed Sponsors

lead

Hospices Civils de Lyon

OTHER